Dr Albert Hsia, DO | |
1435 S Alma School Rd, Chandler, AZ 85286-7144 | |
(480) 668-1600 | |
Not Available |
Full Name | Dr Albert Hsia |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 8 Years |
Location | 1435 S Alma School Rd, Chandler, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518313196 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 7785 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Banner Primary Care Physicians Arizona Llc | 6406020155 | 182 |
News Archive
EyeSouth Partners is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions.
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.
In a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol policies and lower rates of cancer mortality.
› Verified 9 days ago
Entity Name | Heritage Technologies Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093764938 PECOS PAC ID: 5193628485 Enrollment ID: O20040526000631 |
News Archive
EyeSouth Partners is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions.
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.
In a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol policies and lower rates of cancer mortality.
› Verified 9 days ago
Entity Name | Banner Primary Care Physicians Arizona Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417238908 PECOS PAC ID: 6406020155 Enrollment ID: O20111115000898 |
News Archive
EyeSouth Partners is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions.
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.
In a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol policies and lower rates of cancer mortality.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Albert Hsia, DO 1435 S Alma School Rd, Chandler, AZ 85286-7144 Ph: (480) 668-1600 | Dr Albert Hsia, DO 1435 S Alma School Rd, Chandler, AZ 85286-7144 Ph: (480) 668-1600 |
News Archive
EyeSouth Partners is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions.
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.
In a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol policies and lower rates of cancer mortality.
› Verified 9 days ago
Dr. David Bebawy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 S Alma School Rd, Chandler, AZ 85286 Phone: 480-256-7420 Fax: 480-646-3826 | |
Heidi U Rula, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 685 S Dobson Road, Chandler, AZ 85224 Phone: 480-821-2838 Fax: 480-821-9444 | |
Srilakshmi Settipalli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 811 S Hamilton St, Chandler, AZ 85225 Phone: 480-344-6100 Fax: 480-344-6101 | |
Lorretta K Mccarthy, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3960 E Riggs Rd, Suite 1, Chandler, AZ 85249 Phone: 480-786-4441 Fax: 480-786-4609 | |
Kurt Henry Steinke, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1343 N Alma School Rd Ste 160, Chandler, AZ 85224 Phone: 480-963-1853 Fax: 480-726-0695 | |
Neha Maheshwari, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1343 N Alma School Rd, 205, Chandler, AZ 85224 Phone: 480-963-1853 | |
Stephan Zehring, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1435 S Alma School Rd, Chandler, AZ 85286 Phone: 480-668-1600 |